Pediatric nephrologists from Columbia and Weill Cornell Medicine provide compassionate care for newborns to young adults with acute and chronic kidney disease. They remain on the forefront of discoveries that advance prevention, diagnosis, and treatment of these conditions, including renal replacement therapy and transplant for end-stage renal disease.
Pediatric Nephrology
Featured Updates
Results from a new multi-center study, led by oncologists at NewYork-Presbyterian and Weill Cornell Medicine, has described for the first time a key biomarker – absolute lymphocyte count (ALC) – that has the potential to predict therapeutic response to chimeric antigen receptor (CAR) T-cell immunotherapy for patients with relapsed/refractory multiple myeloma. While this FDA-approved treatment is widely used, until now there has not been a way to predict whether B-cell maturation antigen (BCMA) CAR T-cell therapy would elicit a good response.
The Latest
Pediatric Neurology & Neurosurgery
Crossing Specialty Lines for Rare Genetic Neurocutaneous Conditions
